Candriam S.C.A. Neoleukin Therapeutics, Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $131,745 - $400,597	-76,596 Reduced 8.93%	781,577 $1.47 Million
Q3 2021 Nov 09, 2021	BUY	$6.05 - $9.66 $2.09 Million - $3.34 Million	346,160 Added 67.61%	858,173 $6.2 Million
Q2 2021 Jul 20, 2021	BUY	$9.23 - $13.12 $4.73 Million - $6.72 Million	511,978 Added 1462794.25%	512,013 $4.73 Million
Q1 2021 Apr 29, 2021	BUY	$11.26 - $15.78 $394 - $552	35 New	35 $0

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.